814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity

814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity

Bibliographic Details
Main Authors: Mark Throsby, Arpita Mondal, Kees Bol, Wilfred Marissen, Jeroen Elaissais-Schaap, Paul Tacken, Steef Engels, Liang-Chuan Wang, Alan Roberts, Patrick Mayes, Cecile Geuijen
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-fb68b58c8dc743898b32689c799671e6
record_format Article
spelling doaj-fb68b58c8dc743898b32689c799671e62020-12-11T10:04:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0814814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicityMark Throsby0Arpita Mondal1Kees Bol2Wilfred Marissen3Jeroen Elaissais-Schaap4Paul Tacken5Steef Engels6Liang-Chuan Wang7Alan Roberts8Patrick Mayes9Cecile Geuijen10Aff394 Merus N.V. Utrecht Netherlands Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA1Merus N.V., Utrecht, Netherlands1Merus N.V., Utrecht, Netherlands2PD-Value BV, Utrecht, Netherlands1Merus N.V., Utrecht, Netherlands1Merus N.V., Utrecht, Netherlands3Incyte Corporation, Wilmington, DE, USA3Incyte Corporation, Wilmington, DE, USA3Incyte Corporation, Wilmington, DE, USA1Merus N.V., Utrecht, Netherlands
collection DOAJ
language English
format Article
sources DOAJ
author Mark Throsby
Arpita Mondal
Kees Bol
Wilfred Marissen
Jeroen Elaissais-Schaap
Paul Tacken
Steef Engels
Liang-Chuan Wang
Alan Roberts
Patrick Mayes
Cecile Geuijen
spellingShingle Mark Throsby
Arpita Mondal
Kees Bol
Wilfred Marissen
Jeroen Elaissais-Schaap
Paul Tacken
Steef Engels
Liang-Chuan Wang
Alan Roberts
Patrick Mayes
Cecile Geuijen
814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
Journal for ImmunoTherapy of Cancer
author_facet Mark Throsby
Arpita Mondal
Kees Bol
Wilfred Marissen
Jeroen Elaissais-Schaap
Paul Tacken
Steef Engels
Liang-Chuan Wang
Alan Roberts
Patrick Mayes
Cecile Geuijen
author_sort Mark Throsby
title 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
title_short 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
title_full 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
title_fullStr 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
title_full_unstemmed 814 MCLA-145 (CD137xPD-L1): a potent CD137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
title_sort 814 mcla-145 (cd137xpd-l1): a potent cd137 agonist and immune checkpoint inhibitor that that does not show signs of peripheral toxicity
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT markthrosby 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT arpitamondal 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT keesbol 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT wilfredmarissen 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT jeroenelaissaisschaap 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT paultacken 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT steefengels 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT liangchuanwang 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT alanroberts 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT patrickmayes 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
AT cecilegeuijen 814mcla145cd137xpdl1apotentcd137agonistandimmunecheckpointinhibitorthatthatdoesnotshowsignsofperipheraltoxicity
_version_ 1724386520105746432

Similar Items